← Open Payments lookup

MOLLY POWELL: Open Payments

NPI 1811509482 · BERLIN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$961 in 55 payments from 17 companies in 2025. Trend: 2023 $568 · 2024 $1,122 · 2025 $961

Food & beverage: $961
CompanyPaymentsAmount
Novo Nordisk Inc16$269
ABBVIE INC.12$165
AstraZeneca Pharmaceuticals LP7$155
Lilly USA, LLC3$58
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$45
PFIZER INC.2$38
Takeda Pharmaceuticals U.S.A., Inc.2$37
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$34
Exact Sciences Corporation1$25
Inspire Medical Systems, Inc.1$21

Products named: UBRELVY, Rybelsus, BREZTRI, Ozempic, FARXIGA, MOUNJARO, CAPLYTA, VRAYLAR.

Industry payments across NJ — which companies pay providers there.